Phenobarbital Abbott AEROSET/ARCHITECT (c, i, ci models)€¦ · · 2016-02-12Refer to the User Guide for additional information on the EQAS Program, ... DR DANGS LAB PVT LTD D

Customer Information

Lab: 008323

Attn: MS MUKTA SEHGALDR DANGS LAB PVT LTDQAD − 1, HAUZ KHASNEW DELHI NEW DELHI 110016INDIA

Copyright 2014 Bio−Rad Laboratories, Inc. All rights reserved. EQAS is a trademark of Bio−Rad Laboratories, Inc.

Page 1 of 43

¹ Expanded uncertainty coverage factor, k=2Printed on recyclable paper 16 Dec 2014

Exceptions

EQAS News

External Quality Assurance Services

EQASImmunoassay (Monthly) Program (BC70/BC75/BC7L)

Cycle 11: December 2013 − December 2014Sample No: 11 Sample Date: 12 Nov 14

Please be advised that due to the inability to achieve desired levels of Calcitonin

for two cycles of EQAS Immunoassay (Monthly)Program, it is being declaimed.

Calcitonin will no longer be available for reporting after the end of Cycle 11.

IMPORTANT: Place your order for the next cycle now by contacting your Bio−Rad Representative.

Bio−Rad Laboratories is accredited to ISO/IEC 17043:2010.Refer to the User Guide for additional information on the EQAS Program,EQAS reports, their interpretation, statistics, and contact details.

Analyte Instrument Result Unit Z−score Comparator✍ Phenobarbital Abbott AEROSET/ARCHITECT (c, i, ci models)

Legend: ✔ No Warnings ✍ Missing Result ¦ Late Results 2.0 < |Z−score| < 3.0 ✘ |Z−score| > 3.0 * Amended Result (per participant’s request)


EQAS

Configuration ReportImmunoassay (Monthly) ProgramLab 008323

DR DANGS LAB PVT LTDD − 1, HAUZ KHASNEW DELHI NEW DELHI 110016INDIA

Cycle 11Dec 2013 − Dec 2014

Sample No: 11Sample Date: 12 Nov 14

Lot No: 231000

Copyright 2014 Bio−Rad Laboratories, Inc. All rights reserved.EQAS is a trademark of Bio−Rad Laboratories, Inc. Page 2 of 43


Selected Options:Data Input: Online

Report Receipt: QCNet

Subgroup Number: None

Instrument 1392 − Abbott ARCHITECT i1000

Analyte Method Reagent Unit229 C15−3 063 Chemiluminescence 0006 Dedicated Reagent 36 U/mL

070 FOL 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL

132 PHEN 063 Chemiluminescence 0006 Dedicated Reagent 03 µg/mL

133 PHYT 063 Chemiluminescence 0006 Dedicated Reagent 03 µg/mL

388 VALP 063 Chemiluminescence 0006 Dedicated Reagent 03 µg/mL

Instrument 1386 − Abbott ARCHITECT i1000SR

Analyte Method Reagent Unit067 FERR 063 Chemiluminescence 0754 Abbott ARCHITECT Ferritin (7K59) 02 ng/mL

Instrument 1393 − Abbott ARCHITECT i4000

Analyte Method Reagent Unit132 PHEN 063 Chemiluminescence 0006 Dedicated Reagent 03 µg/mL

Instrument 2260 − DiaSorin LIAISON

Analyte Method Reagent Unit600 25VD 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL

Instrument 1030 − DRG International, Inc.

Analyte Method Reagent Unit396 17HP 230 EIA 0006 Dedicated Reagent 02 ng/mL

Instrument 1151 − Roche cobas 6000

Analyte Method Reagent Unit206 AFP 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 02 ng/mL

191 B12 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 01 pg/mL

231 C125 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 36 U/mL

230 C19−9 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 36 U/mL

234 CARB 058 KIMS (Roche) 0006 Dedicated Reagent 03 µg/mL

236 CEA 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 02 ng/mL


EQAS

Configuration ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



Instrument Cont.1151 − Roche cobas 6000

Analyte Method Reagent Unit041 CORT 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 13 µg/dL

428 CPEP 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 02 ng/mL

251 DHEAS 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 13 µg/dL

261 E2 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 01 pg/mL

223 FPSA 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 02 ng/mL

073 FSH 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 34 mIU/mL

179 FT3 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 01 pg/mL

183 FT4 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 12 ng/dL

028 HCG 619 Electrochemiluminescence (ECL) 0861 Roche hCG + B Ref 03271749 34 mIU/mL

299 IGE 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 35 IU/mL

103 INS 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 33 µIU/mL

345 IPTH 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 01 pg/mL

112 LH 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 34 mIU/mL

340 PROG 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 02 ng/mL

341 PROL 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 02 ng/mL

343 PSA 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 02 ng/mL

549 SHBG 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 52 nmol/L

167 TEST 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 02 ng/mL

177 TSH 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 33 µIU/mL

Instrument 1193 − Siemens IMMULITE/1000

Analyte Method Reagent Unit491 HGH 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL

263 UE3 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL


EQAS

Sample Summary ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



Analyte Unit Result Mean Z−score RMZ Comparator✔ CA 15−3 U/mL 18 17.2 0.70 −0.17 Peer

✔ Ferritin ng/mL 24.8 26.2 −0.33 0.50 Peer

✔ Folate ng/mL 2.9 2.91 −0.04 0.44 Peer

✔ Phenobarbital µg/mL 6.98 7.48 −1.17 −0.35 Peer

✍ Phenobarbital

✔ Phenytoin µg/mL 30 30.1 −0.05 0.34 Peer

✔ Valproic Acid µg/mL 190 198 −0.37 −0.22 Peer

Instrument: Abbott AEROSET/ARCHITECT (c, i, ci models)

Analyte Unit Result Mean Z−score RMZ Comparator✔ 25−OH−Vitamin D (Total) ng/mL 24.3 24.0 0.13 0.18 Peer

Instrument: DiaSorin LIASON/XL

Analyte Unit Result Mean Z−score RMZ Comparator✔ 17−a−OH−Progesterone ng/mL 0.9 0.850 0.32 0.14 Peer

Instrument: DRG International, Inc.

Analyte Unit Result Mean Z−score RMZ Comparator✔ AFP ng/mL 49.95 48.3 0.83 −0.20 Peer

✔ C−Peptide ng/mL 2.79 2.86 −0.58 −0.16 Peer

✔ CA 125 U/mL 22.69 22.4 0.25 0.29 Peer

✔ CA 19−9 U/mL 15.8 16.1 −0.34 0.06 Peer

✔ Carbamazepine µg/mL 4.3 4.09 0.99 −0.08 Peer

✔ CEA ng/mL 5.11 5.21 −0.33 −0.01 Peer

✔ Cortisol µg/dL 7.2 7.26 −0.14 0.20 Peer

✔ DHEA−Sulfate µg/dL 99.5* 97.1 0.43 −0.13 Peer

✔ Estradiol (E2) pg/mL 88.5 89.8 −0.19 −0.47 Peer

✔ FSH mIU/mL 14.7 14.6 0.08 0.07 Peer

✔ hCG mIU/mL 5165 5260 −0.36 0.20 Peer

✔ IgE IU/mL 88 89.7 −0.50 −0.19 Peer

✔ Insulin µIU/mL 104.5 105 −0.10 0.20 Peer

✔ Luteinizing Hormone mIU/mL 4.6 4.30 1.55 0.30 Peer

✔ Progesterone ng/mL 17.7 17.6 0.15 −0.17 Peer

✔ Prolactin ng/mL 17.9 17.4 0.60 0.31 Peer

Instrument: Roche cobas 6000/8000/c 311

Legend: ✔ No Warnings ✍ Missing Result ¦ Late Results 2.0 < |Z−score| < 3.0 ✘ |Z−score| > 3.0

* Amended Result (per participant’s request) ³ Non−robust determination of Mean and SD

Problem Classification:

Corrective Action:

Reviewed by: Date:


EQAS

Sample Summary ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



Analyte Unit Result Mean Z−score RMZ Comparator✔ PSA, Free ng/mL 2.83 2.80 0.22 0.33 Peer

✔ PSA, Total ng/mL 19.5 19.5 −0.05 0.11 Peer

✔ PTH, Intact pg/mL 178 181 −0.22 0.11 Peer

✔ SHBG nmol/L 43 43.9 −0.55 −0.32 Peer

✔ T3, Free pg/mL 6.1 6.14 −0.17 −0.46 Peer

✔ T4, Free ng/dL 1.78 1.77 0.13 −0.52 Peer

✔ Testosterone ng/mL 2.05 1.88 1.09 0.05 Peer

✔ TSH µIU/mL 0.72* 0.733 −0.59 0.16 Peer

✔ Vitamin B12 pg/mL 468 468 0.02 −0.26 Peer

Instrument: Roche cobas 6000/8000/c 311

Analyte Unit Result Mean Z−score RMZ Comparator✔ Estriol, Free (UE3) ng/mL 2.72 2.65 0.19 0.00 Peer

✔ Growth Hormone ng/mL 4.1 3.99 0.35 0.40 Peer

Instrument: Siemens IMMULITE/1000

Legend: ✔ No Warnings ✍ Missing Result ¦ Late Results 2.0 < |Z−score| < 3.0 ✘ |Z−score| > 3.0

* Amended Result (per participant’s request) ³ Non−robust determination of Mean and SD

Problem Classification:

Corrective Action:

Reviewed by: Date:


EQAS

CA 15−3 ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



Abbott AEROSET/ARCHITECT (c, i, ci mo...

Your Result

18 U/mL

Comparative Statistics Your Deviation

��¢©®²

N Mean SD CV U¹ Z−score RMZ %

Your Mode 874 19.3 2.17 11.2 0.183 −0.60 −0.94 −6.74

Your Method 583 17.6 2.84 16.1 0.295 0.13 −0.16 2.10

Your Peer 226 17.2 1.15 6.66 0.191 0.70 −0.17 4.63

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date

Dec−13 Jan−14 Feb−14 Mar−14 Apr−14 May−14 Jun−14 Jul−14 Aug−14 Sep−14 Oct−14 Nov−14

11

48.2

15

65.9

12

41.4

12

12.5

09

17.6

14

40.6

11

12.4

09

64.2

13

17.5

10

12.5

08

40.0

12

17.2

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

12.4 40.0 48.2 64.2

��

��

��

��

��

��

��

PEER DISTRIBUTION

11.47 22.94

Your Result

32

METHOD DISTRIBUTION

3.41 31.85

Your Result

94

MODE DISTRIBUTION

8.45 30.15

Your Result

120

N Mean CV U¹

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceDedicated Reagent

226 17.2 6.66 0.191

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Dedicated Reagent

198 20.6 5.55 0.204

Siemens ADVIA Centaur SystemsChemiluminescenceDedicated Reagent

132 19.5 8.59 0.365

Roche Elecsys / cobas e 411 SeriesElectrochemiluminescence (ECL)Dedicated Reagent

99 20.4 6.41 0.328

Beckman Coulter UniCel DxI SeriesChemiluminescenceDedicated Reagent

82 13.2 8.22 0.299

Roche MODULAR (ISE, D, P, E170)Electrochemiluminescence (ECL)Dedicated Reagent

48 20.5 5.08 0.375

bioMérieux VIDAS GroupFIADedicated Reagent

46 20.8 5.60 0.429

Siemens IMMULITE 2000/2500/XPiChemiluminescenceDedicated Reagent

31 24.4 9.63 1.06

Beckman Coulter Access, LXi 725, Dx...ChemiluminescenceDedicated Reagent

27 13.9 11.5 0.767

CA

15

−3 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Ferritin ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

24.8 ng/mL


��¢©®²


Your Mode 1223 28.8 5.05 17.5 0.361 −0.79 0.46 −13.9

Your Method 876 25.5 4.53 17.8 0.383 −0.14 0.80 −2.56

Your Peer 102 26.2 4.09 15.6 1.01 −0.33 0.50 −5.18

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11 15

621

12

869

12

20.5

09

25.1

14

872

11

19.9

09

613

13

25.8

10

19.5

08

853

12

26.2

��

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

19.5 613 853

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

17.16 38.59

Your Result

9

METHOD DISTRIBUTION

2.81 48.09

Your Result

119

MODE DISTRIBUTION

7.88 54.08

Your Result

146

N Mean CV U¹


226 27.1 12.0 0.538


211 32.0 11.8 0.651


181 26.3 14.0 0.685


145 33.2 11.1 0.764


120 21.8 14.6 0.725

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT Ferritin (7K59)

102 26.2 15.6 1.01


74 20.8 16.4 0.992


68 24.3 17.3 1.27

Roche cobas 6000/8000/c 311ImmunoturbidimetricDedicated Reagent

44 36.8 15.0 2.08

Ferritin

11

:C

YC

LE

11

SA

MP

LE


EQAS

Folate ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

2.9 ng/mL


��¢©®²


Your Mode 1032 3.28 0.675 20.6 0.052 −0.56 0.17 −11.5

Your Method 648 2.99 0.616 20.6 0.060 −0.15 0.33 −3.02

Your Peer 205 2.91 0.379 13.0 0.066 −0.04 0.44 −0.465

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

10.1

15

18.8

12

10.2

12

2.1

09

2.8

14

10.3

11

2.1

09

18.7

13

2.9

10

2.1

08

10.2

12

2.9

��

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

2.1 10.1 18.7

��

��

��

��

��

��

��

PEER DISTRIBUTION

1.80 4.81

Your Result

26

METHOD DISTRIBUTION

0.980 6.07

Your Result

81

MODE DISTRIBUTION

0.980 6.65

Your Result

142

N Mean CV U¹


205 2.91 13.0 0.066


179 2.52 11.8 0.055


176 3.66 9.30 0.064


135 3.92 17.9 0.151

Beckman Coulter UniCel DxI SeriesChemiluminescenceBeckman Coulter Access/DxI Folate (REF A98032)

69 3.63 7.42 0.081


41 3.61 7.45 0.105

Siemens IMMULITE 2000/XPiChemiluminescenceDedicated Reagent

36 2.85 8.66 0.103


32 3.57 10.1 0.159

Beckman Coulter Access, LXi 725, Dx...ChemiluminescenceBeckman Coulter Access/DxI Folate (REF A98032)

21 3.53 6.85 0.132

Fola

te 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Phenobarbital ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

6.98 µg/mL


��¢©®²


Your Mode 157 7.45 1.06 14.2 0.211 −0.44 −0.09 −6.25

Your Method 73 7.83 0.789 10.1 0.231 −1.08 −0.54 −10.9

Your Peer 42 7.48 0.426 5.70 0.164 −1.17 −0.35 −6.68

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

51.8

15

71.2

12

39.7

12

5.4

09

7.6

14

39.3

11

5.4

09

70.5

13

7.5

10

5.4

08

39.5

12

7.5

��

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

5.4 39.3 51.8 70.5

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

5.95 9.61

Your Result

7

METHOD DISTRIBUTION

5.00 11.78

Your Result

10

MODE DISTRIBUTION

4.21 12.73

Your Result

20

N Mean CV U¹


42 7.48 5.70 0.164

Roche cobas 6000/8000/c 311KIMS (Roche)Dedicated Reagent

18 6.55 10.4 0.403

Roche cobas INTEGRAFluorescence Polarization−RocheDedicated Reagent

13 6.50 4.84 0.218


12 8.44 8.93 0.544


10 9.06 10.6 0.758

Abbott AxSYMFPIADedicated Reagent

8 6.94 9.15 0.562

Siemens Dimension SeriesImmunoturbidimetricDedicated Reagent

7 8.44 15.7 1.25

Beckman Coulter UniCel DxC SeriesImmunoturbidimetricDedicated Reagent

7 10.9 8.14 0.838

Siemens IMMULITE/1000ChemiluminescenceDedicated Reagent

6 8.54 4.81 0.419

Phenobarb

ital 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Phenobarbital ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

− µg/mL


��¢©®²


Your Mode 157 7.45 1.06 14.2 0.211

Your Method 73 7.83 0.789 10.1 0.231 No comparison possible

Your Peer 42 7.48 0.426 5.70 0.164

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11 15 12 12 09 14 11 09 13 10 08 12

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

PEER DISTRIBUTION

5.95 9.61

7

METHOD DISTRIBUTION

5.00 11.78

10

MODE DISTRIBUTION

4.21 12.73

20

N Mean CV U¹


42 7.48 5.70 0.164


18 6.55 10.4 0.403


13 6.50 4.84 0.218


12 8.44 8.93 0.544


10 9.06 10.6 0.758


8 6.94 9.15 0.562


7 8.44 15.7 1.25


7 10.9 8.14 0.838


6 8.54 4.81 0.419

Phenobarb

ital 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Phenytoin ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

30 µg/mL


��¢©®²


Your Mode 178 29.4 2.28 7.76 0.427 0.27 0.40 2.10

Your Method 115 30.6 3.39 11.1 0.790 −0.18 −0.01 −2.02

Your Peer 59 30.1 1.92 6.37 0.624 −0.05 0.34 −0.301

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

21.5

15

6.6

12

18.1

12

21.6

09

29.5

14

18.2

11

21.6

09

6.6

13

29.4

10

21.2

08

18.1

12

30.1

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

6.6 18.1 21.2 29.4

��

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

20.50 36.10

Your Result

13

METHOD DISTRIBUTION

13.68 39.91

Your Result

21

MODE DISTRIBUTION

17.98 36.10

Your Result

30

N Mean CV U¹


59 30.1 6.37 0.624


25 35.4 5.28 0.936


19 29.7 4.96 0.845


17 29.0 3.03 0.533


15 28.1 10.1 1.84


12 28.0 10.7 2.16


7 32.0 6.07 1.84

VITROS Microslide SeriesEIAVITROS Dry Slides Reagent Group

7 26.9 3.51 0.892


5 28.5 3.38 1.07

Phenyto

in 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Valproic Acid ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

190 µg/mL


��¢©®²


All Results 303 201 16.1 8.01 2.32 −0.70 −0.68 −5.64

Your Method 156 202 14.1 6.97 2.82 −0.88 −0.67 −6.14

Your Peer 75 198 20.3 10.3 5.87 −0.37 −0.22 −3.80

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

114

15

36.9

12

114

12

142

09

193

14

116

11

142

09

36.7

13

197

10

142

08

114

12

198

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

36.7 114 142 193

��

��

��

��

PEER DISTRIBUTION

140.5 299.2

Your Result

14

METHOD DISTRIBUTION

133.0 273.0

Your Result

35

MODE DISTRIBUTION

120.7 282.0

Your Result

61

N Mean CV U¹


75 198 10.3 5.87


42 210 5.25 4.24

Roche cobas 6000/8000/c 311EIADedicated Reagent

31 205 5.31 4.89


27 201 4.49 4.36


³19 198 9.27 5.27


15 200 0.850 1.10


11 199 7.46 11.2

Abbott AEROSET/ARCHITECT (c, i, ci ...ImmunoturbidimetricDedicated Reagent

11 164 14.5 17.9


8 129 11.7 13.3

Valp

roic

Acid

11

:C

YC

LE

11

SA

MP

LE


EQAS

25−OH−Vitamin D (Total) ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



DiaSorin LIASON/XL

Your Result

24.3 ng/mL


��¢©®²


Your Mode 396 22.0 2.69 12.2 0.339 0.85 0.76 10.5

Your Method 380 22.1 2.98 13.5 0.382 0.74 0.65 10.0

Your Peer 74 24.0 2.35 9.81 0.684 0.13 0.18 1.29

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

19.4

15

27.0

12

25.6

12

21.5

09

24.8

14

25.9

11

21.5

09

25.6

13

24.9

10

22.0

08

24.7

12

24.0

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

19.4 21.5 24.0 24.7 25.6 27.0

��

��

��

��

��

PEER DISTRIBUTION

18.60 35.76

Your Result

13

METHOD DISTRIBUTION

8.05 36.99

Your Result

60

MODE DISTRIBUTION

8.53 35.47

Your Result

60

N Mean CV U¹


161 21.1 7.77 0.324


126 22.1 11.0 0.542


92 22.2 10.3 0.595


86 21.2 14.6 0.834

DiaSorin LIASON/XLChemiluminescenceDedicated Reagent

74 24.0 9.81 0.684


21 23.6 5.84 0.750

VITROS Microwell SeriesChemiluminescenceDedicated Reagent

18 36.6 11.0 2.38


16 22.1 14.6 2.02

Roche Elecsys / cobas e 411 SeriesChemiluminescenceDedicated Reagent

10 20.5 13.8 2.23

25

−O

H−Vita

min

D (T

ota

l) 11

:C

YC

LE

11

SA

MP

LE


EQAS

17−a−OH−Progesterone ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



DRG International, Inc.

Your Result

0.9 ng/mL


��¢©®²


Your Mode 107 0.890 0.210 23.6 0.051 0.05 −0.03 1.08

Your Method 52 0.868 0.224 25.8 0.078 0.14 −0.11 3.69

Your Peer 14 0.850 0.155 18.3 0.104 0.32 0.14 5.87

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

10.8

15

17.6

12

9.8

12

0.6

09

0.7

14

9.9

11

0.7

09

17.8

13

0.8

10

0.7

08

10.1

12

0.9

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

0.6 9.8 17.6

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

0.600 1.63

Your Result

2

METHOD DISTRIBUTION

0.366 1.99

Your Result

7

MODE DISTRIBUTION

0.366 1.94

Your Result

17

N Mean CV U¹

DIAsource ImmunoAssaysRIADedicated Reagent

19 1.06 9.06 0.055

Siemens Coat−A−CountRIADedicated Reagent

17 2.58 15.3 0.239

DRG International, Inc.EIADedicated Reagent

14 0.850 18.3 0.104

IBL (IMMUNO BIOLOGICAL LABORATORIES)EIADedicated Reagent

11 0.944 26.5 0.188

Beckman Coulter ImmunotechRIADedicated Reagent

10 0.853 7.95 0.054

Cisbio BioassaysRIADedicated Reagent

8 0.614 18.8 0.102

ManualEIADedicated Reagent

5 0.804 20.5 0.184

Monobind AccuBindEIADedicated Reagent

3 0.421 14.0 0.085

CIS−Bio International RIARIADedicated Reagent

2 0.590 19.0 0.198

17

−a−O

H−P

rogeste

rone 1

1:

CYC

LE

11

SA

MP

LE


EQAS

AFP ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



Roche cobas 6000/8000/c 311

Your Result

49.95 ng/mL


��¢©®²


Your Mode 1270 45.8 3.82 8.34 0.268 1.09 0.45 9.06

Your Method 389 48.1 2.65 5.51 0.336 0.70 −0.07 3.87

Your Peer 212 48.3 2.03 4.21 0.349 0.83 −0.20 3.49

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

26.0

15

11.8

12

29.8

12

35.6

09

48.3

14

30.0

11

35.6

09

11.9

13

48.5

10

35.5

08

30.0

12

48.3

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

11.8 26.0 29.8 35.5 48.3

��

��

��

��

��

��

��

PEER DISTRIBUTION

38.10 56.15

Your Result

32

METHOD DISTRIBUTION

34.83 59.06

Your Result

62

MODE DISTRIBUTION

26.70 60.59

Your Result

164

N Mean CV U¹


212 48.3 4.21 0.349


177 44.4 3.32 0.277


154 48.6 7.35 0.719


123 47.7 8.80 0.947


100 42.7 6.97 0.745


79 44.8 7.47 0.942

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT AFP (7K67)

69 44.5 4.31 0.576


57 41.6 8.85 1.22


56 44.7 7.77 1.16

AFP

11

:C

YC

LE

11

SA

MP

LE


EQAS

C−Peptide ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

2.79 ng/mL


��¢©®²


Your Mode 142 2.84 0.129 4.53 0.027 −0.42 −0.06 −1.89

Your Method 133 2.84 0.129 4.53 0.028 −0.41 −0.07 −1.85

Your Peer 67 2.86 0.127 4.42 0.039 −0.58 −0.16 −2.56

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

5.9

15

7.9

12

5.4

12

2.2

09

2.9

14

5.3

11

2.2

09

7.8

13

2.8

10

2.2

08

5.3

12

2.9

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

2.2 2.8 5.3 7.8

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

2.49 3.50

Your Result

9

METHOD DISTRIBUTION

2.20 3.49

Your Result

20

MODE DISTRIBUTION

2.20 3.49

Your Result

21

N Mean CV U¹


67 1.90 6.20 0.036


67 2.86 4.42 0.039


50 2.81 5.12 0.051


47 2.21 8.17 0.066


41 2.08 6.24 0.051


16 3.16 8.08 0.160


15 2.86 1.82 0.034


8 1.86 3.43 0.056

Siemens ADVIA Centaur CPChemiluminescenceDedicated Reagent

5 2.36 11.0 0.291

C−P

eptid

e 1

1:

CYC

LE

11

SA

MP

LE


EQAS

CA 125 ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

22.69 U/mL


��¢©®²


Your Mode 1060 24.0 2.69 11.2 0.207 −0.49 −0.48 −5.49

Your Method 474 22.4 1.21 5.40 0.139 0.24 0.30 1.32

Your Peer 243 22.4 0.974 4.34 0.156 0.25 0.29 1.10

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

46.7

15

58.8

12

40.5

12

16.3

09

22.4

14

40.4

11

16.2

09

59.4

13

22.7

10

16.4

08

40.6

12

22.4

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

16.2 22.4 40.4 46.7 58.8

��

��

��

��

��

��

��

PEER DISTRIBUTION

17.58 27.31

Your Result

36

METHOD DISTRIBUTION

16.35 28.44

Your Result

69

MODE DISTRIBUTION

10.55 37.47

Your Result

183

N Mean CV U¹


276 26.8 7.78 0.314


243 22.4 4.34 0.156


165 25.3 5.96 0.293


165 22.3 7.76 0.337


86 31.6 6.82 0.581


70 19.8 5.16 0.306


53 22.2 5.36 0.408


43 23.9 9.98 0.909


41 32.1 6.17 0.775

CA

125 1

1:

CYC

LE

11

SA

MP

LE


EQAS

CA 19−9 ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

15.8 U/mL


��¢©®²


Your Mode 650 15.8 1.30 8.26 0.128 0.01 0.14 0.080

Your Method 429 16.1 1.03 6.41 0.124 −0.28 −0.01 −1.77

Your Peer 223 16.1 0.896 5.56 0.150 −0.34 0.06 −1.87

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

25.3

15

39.9

12

28.2

12

12.1

09

16.2

14

27.7

11

12.0

09

38.8

13

16.2

10

12.0

08

27.6

12

16.1

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

12.0 16.1 25.3 38.8

��

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

11.62 20.58

Your Result

36

METHOD DISTRIBUTION

10.93 21.24

Your Result

74

MODE DISTRIBUTION

9.27 22.30

Your Result

116

N Mean CV U¹


237 65.0 10.8 1.14


223 16.1 5.56 0.150


141 16.0 9.17 0.309


131 32.1 9.69 0.679


78 15.2 7.25 0.312


54 20.5 4.78 0.334


50 16.1 5.37 0.306


42 12.0 15.9 0.733


30 16.0 4.63 0.339

CA

19

−9 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Carbamazepine ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

4.3 µg/mL


��¢©®²


All Results 274 4.56 0.601 13.2 0.091 −0.43 −0.60 −5.72

Your Method 20 4.09 0.206 5.03 0.115 1.00 −0.09 5.04

Your Peer 18 4.09 0.212 5.17 0.125 0.99 −0.08 5.14

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11 15 12 12

3.1

09

4.1

14

13.1

11

3.0

09

23.6

13

4.0

10

3.1

08

13.0

12

4.1

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

3.0 13.0 23.6

��

��

��

��

��

��

��

PEER DISTRIBUTION

3.60 5.15

Your Result

4

METHOD DISTRIBUTION

3.60 5.12

Your Result

5

MODE DISTRIBUTION

2.00 7.57

Your Result

41

N Mean CV U¹


37 4.96 6.11 0.125


37 5.12 8.44 0.178


27 4.53 5.07 0.111

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT iCarb, REF 1P36−25

25 5.03 6.24 0.157


23 4.25 12.2 0.269


19 4.01 9.66 0.222


18 4.09 5.17 0.125


9 4.26 4.31 0.153

Abbott AEROSET/ARCHITECT (c, i, ci ...EIADedicated Reagent

8 4.68 5.53 0.229

Carb

am

azepin

e 1

1:

CYC

LE

11

SA

MP

LE


EQAS

CEA ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

5.11 ng/mL


��¢©®²


Your Mode 830 5.11 0.409 7.99 0.035 −0.01 0.16 −0.070

Your Method 481 5.25 0.343 6.53 0.039 −0.42 −0.07 −2.72

Your Peer 254 5.21 0.318 6.10 0.050 −0.33 −0.01 −2.01

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

14.3

15

23.8

12

14.5

12

3.8

09

5.2

14

14.4

11

3.8

09

23.8

13

5.2

10

3.7

08

14.5

12

5.2

��

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

3.7 14.3 23.8

��

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

3.90 6.42

Your Result

33

METHOD DISTRIBUTION

3.54 6.97

Your Result

73

MODE DISTRIBUTION

3.07 7.16

Your Result

119

N Mean CV U¹


286 6.32 5.78 0.054


254 5.21 6.10 0.050


169 4.82 7.88 0.073


167 5.33 6.19 0.064


91 4.93 6.60 0.085


51 4.09 7.50 0.107


50 5.06 6.09 0.109


49 5.18 5.89 0.109


42 6.48 7.33 0.183

CE

A 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Cortisol ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

7.2 µg/dL


��¢©®²


Your Mode 1028 7.47 0.705 9.43 0.055 −0.39 0.00 −3.66

Your Method 386 7.32 0.469 6.41 0.060 −0.26 0.09 −1.69

Your Peer 191 7.26 0.406 5.59 0.073 −0.14 0.20 −0.770

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

22.5

15

34.9

12

21.6

12

5.2

09

7.3

14

21.4

11

5.1

09

35.0

13

7.3

10

5.1

08

21.6

12

7.3

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

5.1 21.4 34.9

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

5.60 9.28

Your Result

28

METHOD DISTRIBUTION

4.98 9.67

Your Result

56

MODE DISTRIBUTION

3.95 11.00

Your Result

153

N Mean CV U¹


191 7.26 5.59 0.073


177 7.41 4.56 0.063


155 7.44 6.63 0.099


151 8.14 8.12 0.134


81 6.70 8.45 0.157


71 7.94 10.2 0.241


44 7.54 9.19 0.261


31 7.16 5.75 0.185


22 5.49 15.3 0.446

Cortis

ol 1

1:

CYC

LE

11

SA

MP

LE


EQAS

DHEA−Sulfate ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

99.5 µg/dL


��¢©®²


Your Mode 267 97.6 7.37 7.55 1.13 0.26 −0.12 2.00

Your Method 255 97.6 7.33 7.51 1.15 0.26 −0.10 1.98

Your Peer 101 97.1 5.72 5.90 1.42 0.43 −0.13 2.52

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

487

15

894

12

499

12

76.8

09

93.9

14

509

11

78.2

09

912

13

96.1

10

78.5

08

508

12

97.1

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

76.8 487 894

��

��

��

��

��

PEER DISTRIBUTION

68.45 125.7

15

METHOD DISTRIBUTION

60.91 134.2

42

MODE DISTRIBUTION

60.71 134.4

43

N Mean CV U¹


113 97.9 8.55 1.97


101 97.1 5.90 1.42


99 62.5 11.1 1.75


85 81.9 6.04 1.34


44 64.2 16.9 4.09


35 66.9 8.02 2.27


33 98.5 9.25 3.97


24 62.9 16.3 5.22


19 69.8 8.80 3.52

DH

EA

−Sulfa

te 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Estradiol (E2) ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

88.5 pg/mL


��¢©®²


Your Mode 658 87.8 9.59 10.9 0.935 0.08 −0.11 0.837

Your Method 485 87.7 8.34 9.50 0.946 0.09 −0.19 0.868

Your Peer 226 89.8 6.99 7.78 1.16 −0.19 −0.47 −1.44

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

312

15

489

12

271

12

70.5

09

85.9

14

272

11

71.3

09

499

13

88.2

10

73.7

08

278

12

89.8

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

70.5 271 489

��

��

��

��

��

��

��

PEER DISTRIBUTION

61.59 124.7

Your Result

33

METHOD DISTRIBUTION

49.86 129.4

Your Result

73

MODE DISTRIBUTION

42.00 135.7

Your Result

100

N Mean CV U¹


261 80.5 7.24 0.902


226 89.8 7.78 1.16


193 84.6 9.59 1.46


138 74.2 9.97 1.57


111 87.8 18.0 3.75


84 73.7 11.4 2.30


63 70.2 13.2 2.91


52 90.1 9.71 3.03


44 92.6 19.7 6.88

Estra

dio

l (E2) 1

1:

CYC

LE

11

SA

MP

LE


EQAS

FSH ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

14.7 mIU/mL


��¢©®²


Your Mode 1555 14.4 1.51 10.5 0.096 0.17 0.06 1.73

Your Method 533 15.0 0.949 6.33 0.103 −0.29 −0.26 −1.86

Your Peer 233 14.6 0.713 4.87 0.117 0.08 0.07 0.370

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

23.5

15

35.2

12

25.3

12

10.7

09

14.6

14

25.5

11

10.8

09

35.4

13

14.7

10

10.8

08

25.5

12

14.6

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

10.7 14.6 23.5 35.2

��

��

��

��

��

��

��

PEER DISTRIBUTION

12.32 18.21

Your Result

29

METHOD DISTRIBUTION

10.24 19.72

Your Result

77

MODE DISTRIBUTION

6.89 22.01

Your Result

202

N Mean CV U¹


292 13.3 4.87 0.095


237 15.5 6.10 0.153


233 14.6 4.87 0.117


173 13.8 6.03 0.158


126 16.1 6.63 0.238


72 16.1 7.27 0.344

Siemens ADVIA Centaur SystemsChemiluminescenceSiemens Centaur/XP FSH, Cal B Lot 41+

70 13.9 6.44 0.267


70 16.4 6.13 0.301


62 12.8 5.74 0.233

FSH

11

:C

YC

LE

11

SA

MP

LE


EQAS

hCG ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

5165 mIU/mL


��¢©®²


Your Mode 978 5016 542 10.8 43.3 0.27 0.43 2.96

Your Method 643 5338 406 7.60 40.0 −0.43 −0.09 −3.25

Your Peer 85 5260 260 4.95 70.6 −0.36 0.20 −1.81

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

3563

15

14.4

12

9776

12

3837

09

5374

14

9713

11

3744

09

13.9

13

5263

10

3754

08

9777

12

5260

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

13.9 3563 5260 9713

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

3958 6561

Your Result

17

METHOD DISTRIBUTION

3310 7366

Your Result

94

MODE DISTRIBUTION

2306 7727

Your Result

153

N Mean CV U¹


350 4567 4.42 27.0


205 5386 8.70 81.8


180 5204 4.63 44.9


128 4756 11.1 117


125 4713 8.92 94.0

Siemens ADVIA Centaur SystemsChemiluminescenceSiemens Centaur ThCG REF 00638631/00643953

96 4697 11.1 133

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche hCG + B Ref 03271749

85 5260 4.95 70.6


78 5026 13.7 195


74 9059 11.5 303

hC

G 1

1:

CYC

LE

11

SA

MP

LE


EQAS

IgE ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

88 IU/mL


��¢©®²


Your Mode 705 85.4 9.77 11.4 0.919 0.26 0.34 3.02

Your Method 281 89.5 4.36 4.88 0.650 −0.33 −0.12 −1.63

Your Peer 119 89.7 3.43 3.82 0.785 −0.50 −0.19 −1.90

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

322

15

518

12

303

12

63.4

09

88.3

14

304

11

64.0

09

521

13

89.4

10

64.4

08

304

12

89.7

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

63.4 303 518

��

��

��

��

��

��

��

PEER DISTRIBUTION

72.58 106.8

Your Result

17

METHOD DISTRIBUTION

67.65 111.3

Your Result

43

MODE DISTRIBUTION

36.59 134.2

Your Result

110

N Mean CV U¹


132 89.6 5.62 1.10


119 89.7 3.82 0.785


91 76.5 5.41 1.08


65 97.7 8.50 2.58


52 82.1 4.82 1.37


42 83.0 8.77 2.81


29 68.4 11.7 3.72


25 97.3 4.52 2.20

Abbott AEROSET/ARCHITECT (c, i, ci ...ImmunoturbidimetricDedicated Reagent

19 70.2 8.21 3.31

IgE

11

:C

YC

LE

11

SA

MP

LE


EQAS

Insulin ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

104.5 µIU/mL


��¢©®²


Your Mode 545 101 8.59 8.52 0.920 0.44 0.65 3.72

Your Method 292 105 5.62 5.34 0.822 −0.13 0.18 −0.690

Your Peer 130 105 4.73 4.50 1.04 −0.10 0.20 −0.464

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

54.9

15

17.5

12

61.9

12

76.9

09

107

14

62.7

11

77.1

09

17.6

13

105

10

77.0

08

62.2

12

105

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

17.5 54.9 76.9 105

��

��

��

��

��

��

��

PEER DISTRIBUTION

87.19 115.7

Your Result

14

METHOD DISTRIBUTION

77.13 130.1

Your Result

47

MODE DISTRIBUTION

57.81 143.7

Your Result

76

N Mean CV U¹


151 93.5 3.39 0.645


130 105 4.50 1.04


126 106 5.75 1.35


79 164 5.39 2.49


49 32.5 20.8 2.42


43 100 6.84 2.61


30 97.7 5.70 2.54


29 104 7.19 3.46

Tosoh AIA ModelsEIADedicated Reagent

17 111 6.25 4.21

Insulin

11

:C

YC

LE

11

SA

MP

LE


EQAS

Luteinizing Hormone ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

4.6 mIU/mL


��¢©®²


Your Mode 919 4.05 0.492 12.2 0.041 1.13 0.52 13.7

Your Method 531 4.30 0.233 5.42 0.025 1.30 0.36 7.04

Your Peer 237 4.30 0.191 4.44 0.031 1.55 0.30 6.87

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

22.1

15

43.0

12

24.4

12

3.3

09

4.4

14

24.5

11

3.3

09

43.1

13

4.3

10

3.2

08

24.3

12

4.3

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

3.2 22.1 43.0

��

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

3.56 5.26

Your Result

35

METHOD DISTRIBUTION

3.13 5.46

Your Result

81

MODE DISTRIBUTION

1.65 6.51

Your Result

163

N Mean CV U¹


254 3.51 6.28 0.035


252 3.09 6.03 0.029


237 4.30 4.44 0.031


235 4.28 6.54 0.046


124 3.04 7.40 0.050


72 3.09 7.32 0.067


69 3.09 8.96 0.083


64 13.0 13.0 0.530


45 4.30 4.01 0.064

Lute

iniz

ing H

orm

one 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Progesterone ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

17.7 ng/mL


��¢©®²


Your Mode 845 17.2 1.36 7.89 0.117 0.38 0.08 2.99

Your Method 414 17.7 0.914 5.15 0.112 −0.03 −0.28 −0.156

Your Peer 196 17.6 0.745 4.24 0.133 0.15 −0.17 0.646

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

8.8

15

2.3

12

9.1

12

14.0

09

17.5

14

9.1

11

14.0

09

2.4

13

17.6

10

14.2

08

9.2

12

17.6

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

2.3 8.8 14.0 17.5

��

��

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

15.22 21.31

Your Result

23

METHOD DISTRIBUTION

13.16 22.30

Your Result

60

MODE DISTRIBUTION

10.41 23.96

Your Result

133

N Mean CV U¹


227 13.9 7.07 0.163


196 17.6 4.24 0.133


192 17.1 7.26 0.224


164 18.0 6.00 0.211


113 15.5 7.44 0.272


69 20.8 8.11 0.507


62 12.5 8.12 0.323


49 16.1 6.21 0.358


44 17.5 4.46 0.294

Pro

geste

rone 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Prolactin ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

17.9 ng/mL


��¢©®²


Your Mode 946 16.8 1.61 9.58 0.131 0.70 0.62 6.75

Your Method 525 17.7 0.922 5.21 0.101 0.24 0.15 1.27

Your Peer 226 17.4 0.759 4.35 0.126 0.60 0.31 2.60

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

94.4

15

44.0

12

30.6

12

12.7

09

17.6

14

30.6

11

12.6

09

44.2

13

17.5

10

12.5

08

30.5

12

17.4

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

12.5 30.5 44.0 94.4

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

14.75 21.24

Your Result

34

METHOD DISTRIBUTION

13.07 22.28

Your Result

78

MODE DISTRIBUTION

8.74 24.80

Your Result

146

N Mean CV U¹


248 12.1 6.46 0.124


235 18.0 6.42 0.189


226 17.4 4.35 0.126


140 15.5 6.92 0.227


127 12.9 4.79 0.137

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCH Prol 7K76, Cal Lot 24903U100+

112 15.2 5.45 0.196


72 13.1 5.89 0.228


61 15.3 5.72 0.280


57 12.5 6.34 0.262

Pro

lactin

11

:C

YC

LE

11

SA

MP

LE


EQAS

PSA, Free ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

2.83 ng/mL


��¢©®²


Your Mode 868 2.79 0.164 5.88 0.014 0.22 0.28 1.31

Your Method 389 2.81 0.140 4.96 0.018 0.11 0.24 0.543

Your Peer 206 2.80 0.137 4.89 0.024 0.22 0.33 1.08

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

3.0

15

3.1

12

3.0

12

2.1

09

2.8

14

3.0

11

2.1

09

3.0

13

2.8

10

2.0

08

2.9

12

2.8

��

��

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

2.0 2.8

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

2.13 3.44

Your Result

32

METHOD DISTRIBUTION

2.12 3.51

Your Result

56

MODE DISTRIBUTION

1.97 3.61

Your Result

125

N Mean CV U¹


255 2.79 5.37 0.023


206 2.80 4.89 0.024


125 2.84 5.98 0.038


101 2.80 4.86 0.034


54 3.97 4.48 0.060


47 2.80 4.05 0.041


33 2.57 9.17 0.102


29 3.51 7.04 0.115

Beckman Coulter UniCel DxI SeriesChemiluminescenceBeckman Coulter PSA, WHO Calibration

26 3.82 8.35 0.156

PSA

, Fre

e 1

1:

CYC

LE

11

SA

MP

LE


EQAS

PSA, Total ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

19.5 ng/mL


��¢©®²


Your Mode 1455 19.3 1.34 6.92 0.088 0.14 0.38 0.993

Your Method 630 19.6 0.891 4.55 0.089 −0.11 0.08 −0.491

Your Peer 292 19.5 0.748 3.83 0.109 −0.05 0.11 −0.178

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

48.7

15

7.6

12

13.6

12

14.2

09

19.7

14

13.7

11

14.2

09

7.6

13

19.7

10

14.2

08

13.7

12

19.5

��

��

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

7.6 13.6 19.5 48.7

��

��

��

��

��

��

PEER DISTRIBUTION

15.79 23.28

Your Result

43

METHOD DISTRIBUTION

15.14 24.05

Your Result

94

MODE DISTRIBUTION

12.63 25.99

Your Result

211

N Mean CV U¹


372 19.7 5.84 0.149


292 19.5 3.83 0.109


271 19.7 5.38 0.161


206 17.3 6.48 0.195


68 22.6 5.32 0.364


53 23.1 4.85 0.385


53 20.3 6.70 0.468


53 19.4 4.77 0.318

Beckman Coulter UniCel DxI SeriesChemiluminescenceBeckman Coulter PSA, WHO Calibration

40 22.7 6.86 0.617

PSA

, Tota

l 11

:C

YC

LE

11

SA

MP

LE


EQAS

PTH, Intact ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

178 pg/mL


��¢©®²


Your Mode 522 190 19.5 10.2 2.13 −0.63 −0.43 −6.48

Your Method 409 186 15.8 8.48 1.95 −0.50 −0.31 −4.27

Your Peer 129 181 11.9 6.57 2.61 −0.22 0.11 −1.45

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

247

15

17.7

12

102

12

133

09

182

14

100.0

11

132

09

17.8

13

181

10

133

08

101

12

181

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

17.7 100.0 132 181 247

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

139.3 207.7

Your Result

20

METHOD DISTRIBUTION

107.1 264.8

Your Result

59

MODE DISTRIBUTION

92.81 287.9

Your Result

74

N Mean CV U¹


129 181 6.57 2.61


121 195 7.85 3.48


116 290 7.34 4.95


67 435 11.5 15.3


67 348 9.16 9.74

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche ECL PTH (1−84), REF 05608546

40 174 8.96 6.15


39 213 8.06 6.87

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCH iPTH, (Routine mode, assay file 581)

37 417 12.9 22.1


28 168 12.5 9.95

PTH

, Inta

ct 1

1:

CYC

LE

11

SA

MP

LE


EQAS

SHBG ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

43 nmol/L


��¢©®²


Your Mode 215 44.3 2.97 6.69 0.506 −0.45 −0.40 −3.02

Your Method 94 43.8 1.80 4.11 0.465 −0.45 −0.26 −1.85

Your Peer 45 43.9 1.71 3.89 0.637 −0.55 −0.32 −2.13

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

37.0

15

47.3

12

45.7

12

30.3

09

43.3

14

44.8

11

30.1

09

47.9

13

43.5

10

30.7

08

45.5

12

43.9

��

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

30.1 37.0 43.3

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

35.39 50.00

Your Result

9

METHOD DISTRIBUTION

34.80 52.82

Your Result

15

MODE DISTRIBUTION

29.50 59.18

Your Result

37

N Mean CV U¹


58 44.2 7.19 1.04


45 43.9 3.89 0.637


29 43.9 4.93 1.00


24 47.6 10.3 2.50


16 43.1 3.97 1.07


15 47.9 6.02 1.86


13 57.9 4.23 1.70


7 42.3 4.37 1.75


4 48.5 4.59 2.79

SH

BG

11

:C

YC

LE

11

SA

MP

LE


EQAS

T3, Free ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

6.1 pg/mL


��¢©®²


Your Mode 1607 5.46 0.718 13.2 0.045 0.90 0.66 11.8

Your Method 553 6.09 0.286 4.70 0.030 0.02 −0.29 0.105

Your Peer 246 6.14 0.242 3.95 0.039 −0.17 −0.46 −0.654

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

13.9

15

21.8

12

14.3

12

4.8

09

6.0

14

14.4

11

4.9

09

22.2

13

6.1

10

4.9

08

14.7

12

6.1

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

4.8 13.9 21.8

��

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

5.10 7.35

Your Result

41

METHOD DISTRIBUTION

4.66 7.53

Your Result

99

MODE DISTRIBUTION

1.87 9.05

Your Result

315

N Mean CV U¹


335 4.98 6.38 0.043


270 5.12 3.42 0.027


246 6.14 3.95 0.039


243 6.03 5.01 0.048


131 4.61 7.62 0.077


63 4.95 6.08 0.095


47 5.10 2.57 0.048


47 6.08 3.83 0.085


42 5.42 10.2 0.214

T3, F

ree 1

1:

CYC

LE

11

SA

MP

LE


EQAS

T4, Free ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

1.78 ng/dL


��¢©®²


Your Mode 1798 1.52 0.285 18.7 0.017 0.92 0.77 17.2

Your Method 631 1.77 0.064 3.58 0.006 0.12 −0.41 0.419

Your Peer 226 1.77 0.054 3.07 0.009 0.13 −0.52 0.401

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

2.8

15

7.8

12

6.8

12

1.5

09

1.7

14

6.9

11

1.5

09 13

1.8

10

1.6

08

7.0

12

1.8

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

1.5 2.8 6.8 7.8

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

1.50 2.05

Your Result

35

METHOD DISTRIBUTION

1.45 2.09

Your Result

83

MODE DISTRIBUTION

0.121 2.94

Your Result

397

N Mean CV U¹


345 1.39 4.73 0.009


285 1.22 6.62 0.012


235 1.77 4.22 0.012


226 1.77 3.07 0.009


138 1.25 6.39 0.017


77 1.30 5.87 0.022


53 1.66 4.74 0.027


52 1.34 5.29 0.025

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche ECL FT4 II, REF 06437281

43 1.76 2.69 0.018

T4, F

ree 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Testosterone ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

2.05 ng/mL


��¢©®²


Your Mode 698 2.06 0.286 13.9 0.027 −0.03 −0.37 −0.405

Your Method 449 1.93 0.214 11.1 0.025 0.56 −0.16 6.19

Your Peer 189 1.88 0.159 8.45 0.029 1.09 0.05 9.18

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

8.7

15

13.5

12

7.9

12

1.5

09

2.0

14

8.0

11

1.6

09

13.1

13

2.0

10

1.5

08

7.9

12

1.9

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

1.5 7.9 13.1

��

��

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

1.08 2.50

Your Result

26

METHOD DISTRIBUTION

0.860 3.00

Your Result

69

MODE DISTRIBUTION

0.626 3.49

Your Result

88

N Mean CV U¹


201 1.42 9.75 0.024


196 1.98 12.9 0.046


189 1.88 8.45 0.029


112 2.31 6.64 0.036


107 1.37 7.47 0.025

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT Testosterone, REF 2P13

66 2.26 7.31 0.051


62 1.65 17.1 0.090


52 1.66 12.2 0.071


51 1.47 8.74 0.045

Testo

ste

rone 1

1:

CYC

LE

11

SA

MP

LE


EQAS

TSH ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

0.72 µIU/mL


��¢©®²


Your Mode 1872 0.665 0.089 13.5 0.005 0.62 0.72 8.28

Your Method 658 0.737 0.028 3.76 0.003 −0.60 0.01 −2.27

Your Peer 294 0.733 0.023 3.08 0.003 −0.59 0.16 −1.82

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

22.2

15

47.2

12

23.9

12

0.6

09

0.8

14

23.7

11

0.6

09

46.7

13

0.7

10

0.6

08

23.5

12

0.7

��

��

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

0.6 22.2 46.7

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

0.620 0.846

52

METHOD DISTRIBUTION

0.598 0.875

100

MODE DISTRIBUTION

0.334 1.11

266

N Mean CV U¹


383 0.569 5.71 0.004


294 0.733 3.08 0.003


290 0.741 4.31 0.005

Siemens ADVIA Centaur SystemsChemiluminescenceSiemens Centaur TSH3−Ultra, REF 06491080

150 0.621 4.61 0.006


101 0.622 7.51 0.012


92 0.665 9.64 0.017


74 0.645 5.87 0.011

Siemens ADVIA Centaur SystemsChemiluminescenceSiemens Centaur TSH, REF 08700387

71 0.738 4.74 0.010


51 0.734 4.54 0.012

TSH

11

:C

YC

LE

11

SA

MP

LE


EQAS

Vitamin B12 ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000




Your Result

468 pg/mL


��¢©®²


Your Mode 1026 473 35.8 7.56 2.79 −0.15 −0.10 −1.12

Your Method 462 474 29.3 6.18 3.41 −0.21 −0.19 −1.28

Your Peer 215 468 20.2 4.31 3.44 0.02 −0.26 0.090

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

773

15

1044

12

763

12

358

09

479

14

744

11

349

09

1013

13

472

10

347

08

729

12

468

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

347 468 729 1013

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

366.8 568.4

Your Result

28

METHOD DISTRIBUTION

327.6 620.5

Your Result

68

MODE DISTRIBUTION

294.5 652.1

Your Result

161

N Mean CV U¹


245 483 8.61 6.64


216 466 7.29 5.77


215 468 4.31 3.44


198 488 8.68 7.53


136 387 8.70 7.22


62 399 10.7 13.5


38 464 3.84 7.22


32 440 9.89 19.2

VITROS Microwell SeriesChemiluminescenceDedicated Reagent

29 451 7.12 14.9

Vita

min

B12

11

:C

YC

LE

11

SA

MP

LE


EQAS

Estriol, Free (UE3) ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



Siemens IMMULITE/1000

Your Result

2.72 ng/mL


��¢©®²


Your Mode 92 2.54 0.288 11.3 0.075 0.62 0.36 7.01

Your Method 115 2.35 0.474 20.2 0.110 0.79 0.51 15.9

Your Peer 23 2.65 0.374 14.1 0.195 0.19 0.00 2.71

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

1.8

15

0.2

12

1.7

12

2.5

09

2.6

14

1.7

11

2.4

09

0.3

13

2.7

10

2.3

08

1.7

12

2.6

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

0.2 1.7 2.3

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

1.78 3.34

Your Result

3

METHOD DISTRIBUTION

0.470 4.72

Your Result

23

MODE DISTRIBUTION

1.78 3.98

Your Result

16

N Mean CV U¹


55 2.46 8.73 0.072


23 2.65 14.1 0.195


21 0.734 12.5 0.050


7 0.678 7.25 0.046

Siemens IMMULITE 2000/2500/XPiChemiluminescenceSiemens IMMULITE Unconjugated Estriol, UE3

6 2.60 5.07 0.134

SNIBE MaglumiChemiluminescenceDedicated Reagent

2 4.43 44.4 3.47

DRG International, Inc.EIADedicated Reagent

2 2.73 25.0 1.20

Wallac AutoDELFIA/DELFIAChemiluminescenceDedicated Reagent

1 2.74 0 0

ManualEIADia.Metra

1 2.66 0 0

Estrio

l, Fre

e (U

E3

) 11

:C

YC

LE

11

SA

MP

LE


EQAS

Growth Hormone ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



Siemens IMMULITE/1000

Your Result

4.1 ng/mL


��¢©®²


Your Mode 195 4.38 0.467 10.7 0.084 −0.60 −0.04 −6.43

Your Method 234 4.19 0.640 15.3 0.105 −0.14 0.35 −2.14

Your Peer 37 3.99 0.304 7.61 0.125 0.35 0.40 2.67

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

12.8

15

25.4

12

13.8

12

3.0

09

4.0

14

13.7

11

3.1

09

25.5

13

4.1

10

3.0

08

13.6

12

4.0

��

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

3.0 12.8 25.4

��

��

��

��

��

��

��

��

��

PEER DISTRIBUTION

3.00 4.97

Your Result

5

METHOD DISTRIBUTION

1.62 7.39

Your Result

29

MODE DISTRIBUTION

2.90 6.72

Your Result

21

N Mean CV U¹


109 4.60 7.20 0.079


37 3.99 7.61 0.125


31 2.89 5.12 0.066


27 3.36 4.22 0.068


23 2.90 4.61 0.070


19 3.51 5.92 0.119

Siemens IMMULITE 2000/2500/XPiChemiluminescenceSiemens IMMULITE GRH hGH Assay (98/574)

13 4.53 5.04 0.158


13 3.88 6.26 0.168

Cisbio BioassaysRIADedicated Reagent

6 3.73 11.4 0.435

Gro

wth

Horm

one 1

1:

CYC

LE

11

SA

MP

LE


EQAS

Data on File ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



Sample Numbers

Analyte Unit 1 2 3 4 5 6 7 8 9 10 11 12

C15−3 U/mL 55.2 42.2 13 16.4 39.8 12 63.1* 17.5 12.2 38.2 18

✔ FOL ng/mL 19.6 10.2 1.9 2.8 11.3 2.4 18* 3 2.3 11.5 2.9

✔ PHEN µg/mL 76.42 39.62 5.81 8.01 38.5 5 70.2* 7.8 5.3 38.5 6.98

PHYT µg/mL 6.81 17.47 21.07 26.4 ¦ 19.5 22.5 7.3 30.51 20.5 17.5 30

✔ VALP µg/mL 36.34 115.52 155 177.41 113.67 137.3 37.12 195 139 113 190

Instrument: Abbott ARCHITECT i1000

FERR ng/mL 536.7* 756.9* 20.93* 22.93* 725* ¦ 23* 610.31 27 24.19 899 24.8

Instrument: Abbott ARCHITECT i1000SR

PHEN µg/mL − − − − − − − − − − −

Instrument: Abbott ARCHITECT i4000

CARB µg/mL 24.8 14 − − − − − − − − −

Instrument: Abbott AxSYM

25VD ng/mL 26.5 27.8 18.4 25.6 26 23.4 ¦ 25 25.1 22 25.4 24.3

Instrument: DiaSorin LIAISON

17HP ng/mL 19.2 14.1 0.74 0.81 ¦ 10.5 0.64 19 0.82 0.76 9.79 0.9

Instrument: DRG International, Inc.

✔ AFP ng/mL 12.24 30.92 32.21 42.42 29 35 12* 44.97 34.8 29.8 49.95

CPEP ng/mL 8.16 5.2 2.1 2.61 5.1 2.26 7.9 2.82 2.1 5.2 2.79

✔ C125 U/mL 59.03 41.63 16.03 22.8 41.5 16.66 61 23.43 15.9 41 22.69

✔ C19−9 U/mL 38.37 28.44 12.02 15.44 29 11.41 41 16.58 12.1 27 15.8

CARB µg/mL − − 3 4.1 13.6 3 21.5 4 3.1 12.9 4.3

✔ CEA ng/mL 24.59 14.45 3.98 5.66 15.2 3.7 23.98 5.29 3.7 14.8 5.11

✔ CORT µg/dL 32.31 21.35 5.43 7.59 22.04 5.4 35.5 7.77 5.4 20 7.2

✔ DHEAS µg/dL 890 461.5 73.29 95.69 499.3 76.77 920* 94.87 75 502 99.5*

✔ E2 pg/mL 458.6 262.5 68.34 91.9 270.7 68 490 83.72 69.83 273.4 88.5

✔ FSH mIU/mL 35.84 25.32 11.25 14.75 24 10.52 35.37 14.99 10.87 25.92 14.7

✔ HCG mIU/mL 15.55 10563 3822 5267 10187 3775 14* 5507 3780 9895 5165

✔ IGE IU/mL 533.9 302.4 66.36 87.17 307 63 510 88.8* 66* 301 88

✔ INS µIU/mL 16.41 63.33 74.51 106.3 62 80.97 17.48 106.4 79.2 61 104.5

✔ LH mIU/mL 44.25 25.1 3.33 4.41 23.8 3.4 42 4.28* 3.35 24 4.6

✔ PROG ng/mL 2.26 9.18 13.01 17.42 9.59 14.01 2.51 17.1 13.88 8.9 17.7

✔ PROL ng/mL 44.37 32.95 13.2* 19.41 30 12.5 45 17.93 13 29.8 17.9

Instrument: Roche cobas 6000

Legend: ✔ No Warnings ¦ Late Results 2.0 < |Z−score| < 3.0 |Z−score| > 3.0 − No Result

* Amended Result (per participant’s request)


EQAS

Data on File ReportImmunoassay (Monthly) ProgramLab 008323




Lot No: 231000



Sample Numbers

Analyte Unit 1 2 3 4 5 6 7 8 9 10 11 12

✔ FPSA ng/mL 2.96 3.07 2.1 2.74 2.94 2.05 3.19 2.83* 2.12 2.9 2.83

✔ PSA ng/mL 7.94 13.49 14.56 18.67 13.39 14.67 7.83 19.18 14.3 13.5 19.5

✔ IPTH pg/mL 17.62 97.87 143.7 175 104 136 18.02 185 131.5 99.24 178

✔ SHBG nmol/L 45.66 43.06 31.7* 43.02 45 29 48.5 43.33 29.95 46.08 43

✔ FT3 pg/mL 21.88 14.41 4.99 6.26 13.99 5.1 20.74 5.93 4.73 14.5 6.1

FT4 ng/dL 7.77* 6.22 1.56* 1.66 6.84 1.59* − 1.65 1.46 7.15* 1.78

✔ TEST ng/mL 12.74 7.63 1.35 1.7 8.1 1.49 13.6 1.8 1.52 8.2 2.05

✔ TSH µIU/mL 46.88 23.12 0.604 0.716 23.24 0.58 46.37 0.75 0.588 22.8 0.72*

✔ B12 pg/mL 1025 759.2 373.2 515.6 780 365 975 455 335 725 468

Instrument: Roche cobas 6000

✔ UE3 ng/mL 0.24 1.56 2.3* 2.52 1.6 2.7 0.2 2.9 2.1 1.65 2.72

✔ HGH ng/mL 26.3 15.6 3.13* 4.23 13 3* 27.5 4.2 3.13 13.9 4.1

Instrument: Siemens IMMULITE/1000

Legend: ✔ No Warnings ¦ Late Results 2.0 < |Z−score| < 3.0 |Z−score| > 3.0 − No Result

* Amended Result (per participant’s request)

Documents

Phenobarbital Abbott AEROSET/ARCHITECT (c, i, ci models)€¦ · · 2016-02-12Refer to the User Guide for additional information on the EQAS Program, ... DR DANGS LAB PVT LTD D